Results 141 to 150 of about 19,108 (217)

Myokines in exercise‑mediated bone homeostasis: Molecular signaling mechanisms and therapeutic implications for bone disorders (Review). [PDF]

Int J Mol Med
Tian B, Chen X, Zheng J, Kang X.
europepmc   +1 more source

Cardiac safety of chronic inhibition of the myostatin-activin pathway with bimagrumab in healthy older adults.

J Clin Endocrinol Metab
Rooks D, Yates DP, Neelakantham S, Praestgaard J, Cury RC, Lamb HJ, Roubenoff R, Petricoul O, Lach-Trifilieff E, Svensson EC.   +9 more
europepmc   +1 more source

Perspectives on the Nutritional Paradox in Uremia: A "Sensitize-Then-Feed" Framework for Protein-Energy Wasting. [PDF]

Adv Nutr
Li M, Chen Z, Liu N, Lan N, Zeng F, Xue C, Yang B.   +6 more
europepmc   +1 more source

Exerkines in precision management of metabolic diseases. [PDF]

Chin Med J (Engl)
Jin L, Lin Y, Zheng Y, Wang A, Liao P, Luo Y, Sui Z, Ni X, Zhang J, Shen Q, Xu A.   +10 more
europepmc   +1 more source

Aging of Skeletal Muscle: From Molecular Mechanisms to Therapeutic Interventions. [PDF]

MedComm (2020)
Liu T, Hu Y.
europepmc   +1 more source

Association between vitamin D status and circulating myokines (irisin, myostatin, and myonectin) in children: A cross-sectional study. [PDF]

PLoS One
Buyukinan M, Kurku H, Bagci Z, Gederet YT, Yilmaz AF.   +4 more
europepmc   +1 more source

Myostatin Inhibitory D‑Peptides Induce Skeletal Muscle Hypertrophy along with Alteration of Bioactive Sphingolipid Metabolism. [PDF]

ACS Pharmacol Transl Sci
Morito K, Nishikawa N, Hitachi K, Tamaki R, Nishikawa M, Hayashi Y, Tsuchida K, Takayama K.   +7 more
europepmc   +1 more source

Omega-3 Fatty Acids Attenuate Renal Myostatin Expression and Mitochondrial Alterations Under Uremic Conditions. [PDF]

Int J Mol Sci
Lee SM, Jeong YI, Jung S, Yang DE, Rha SH, Kim SE, An WS.   +6 more
europepmc   +1 more source

Slow and fast locomotor muscle adaptations to sustained intermittent hypoxaemia. [PDF]

J Physiol Sci
Paprzycki L, Jenart V, Legrand A, Michiels C, Tassin A.   +4 more
europepmc   +1 more source

Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response. [PDF]

Ann Clin Transl Neurol
Riolo G, Dosi C, Parravicini S, Zanin R, Cheli M, Grigoli EG, Canciello A, Andreetta F, Masson R, Bonanno S, Marcuzzo S, Maggi L.   +11 more
europepmc   +1 more source